Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| GLOBAL GEOPH | GGS | 7.79% |
| STAAR SURGIC | STAA | 6.23% |
| KAPSTONE PAP | KS | 6.14% |
| HORNBECK OFF | HOS | 5.99% |
| ANIKA THERAP | ANIK | 5.55% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Altera Corporation (ALTR - Analyst Report) declared senior notes pricing of its 1.75% Senior Notes with principal amount $500 million, due to mature in 2017. The company is likely to close the transaction on May 8, 2012.
Book-running managers currently acting for this notes offering are J.P. Morgan Securities L.L.C., Merrill Lynch, Pierce, Fenner & Smith Incorporated and Morgan Stanley & Co. LLC.
The net proceeds from the offering along with its cash balances shall be used to repay the company’s outstanding loans of nearly $500 million which would then result in the termination of Altera’s Credit Agreement, dated August 31, 2007.
The company declared quite a weakened performance in its first quarter financial results of 2012, reported on April 19, 2012. Revenues dropped around 28% annually to reach $384 million in the quarter. Margins were under pressure too as operating margin declined substantially from 45.8% in the year-ago quarter to 30.4% in the first quarter of 2012.
Furthermore, the company pertains to an industry where ominous competition is prevalent. It should stay cautious of big players such as Lattice Semiconductor Corporation (LSCC - Snapshot Report) and Xilinx Inc. (XLNX - Analyst Report) as it traverses through 2012.
Moving forward, the company is hopeful of strong recovery in the upcoming quarter of 2012 where it expects sales to be within the range of $437.5 million - $452.9 million, rising approximately 14% - 18% sequentially. The Zacks Consensus Estimate for the fiscal years 2012 and 2013 stands at $1.69 and $2.15, representing 27.91% year over year decline and 27.08% growth, respectively.
In the short run, the stock bears a Zacks #3 Rank, which translates into a short-term Hold rating. Additionally, we currently maintain a long-term Neutral recommendation on the stock.
Get the full Analyst Report on ALTR - FREE
Get the full Analyst Report on XLNX - FREE
Get the full Snapshot Report on LSCC - FREE